Bionime Corporation (4737.TW)
- Previous Close
60.00 - Open
58.10 - Bid 61.50 x --
- Ask 61.60 x --
- Day's Range
58.10 - 61.50 - 52 Week Range
47.45 - 72.50 - Volume
38,006 - Avg. Volume
34,084 - Market Cap (intraday)
3.74B - Beta (5Y Monthly) 0.29
- PE Ratio (TTM)
-- - EPS (TTM)
-2.09 - Earnings Date --
- Forward Dividend & Yield 2.00 (3.25%)
- Ex-Dividend Date Jul 29, 2024
- 1y Target Est
--
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, the United Arab Emirates, Egypt, and internationally. The company offers blood glucose meters and self-monitors, as well as accessories, such as test strips and lancing devices to medical equipment manufacturers, pharmacies, and hospitals. It is also involved in the provision of biotechnology services; drug testing; wholesale of precision instruments; and manufacturing of medical equipment, etc. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.
www.bionime.comRecent News: 4737.TW
View MorePerformance Overview: 4737.TW
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4737.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4737.TW
View MoreValuation Measures
Market Cap
3.65B
Enterprise Value
6.43B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.89
Price/Book (mrq)
1.94
Enterprise Value/Revenue
3.33
Enterprise Value/EBITDA
108.51
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.33%
Return on Assets (ttm)
-1.63%
Return on Equity (ttm)
-4.34%
Revenue (ttm)
1.92B
Net Income Avi to Common (ttm)
-83.24M
Diluted EPS (ttm)
-2.09
Balance Sheet and Cash Flow
Total Cash (mrq)
387.35M
Total Debt/Equity (mrq)
159.50%
Levered Free Cash Flow (ttm)
-123.76M